Patents by Inventor Enrique Arevalo

Enrique Arevalo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220056109
    Abstract: Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.
    Type: Application
    Filed: October 22, 2021
    Publication date: February 24, 2022
    Inventors: Hetal Sarvaiya, Nathaniel J. Washburn, Enrique Arevalo, Carlos J. Bosques
  • Publication number: 20200109432
    Abstract: The present disclosure relates to methods of evaluating, identifying, and/or producing (e.g., manufacturing) pharmaceutical products (e.g., protein therapeutics). In some instances, methods herein allow highly resolved evaluation of the disulfide bond profiles of protein therapeutics.
    Type: Application
    Filed: July 8, 2019
    Publication date: April 9, 2020
    Inventors: Brian Collins, John Robblee, Nathaniel Washburn, Yan Yin, Enrique Arevalo
  • Publication number: 20180305440
    Abstract: Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.
    Type: Application
    Filed: April 19, 2018
    Publication date: October 25, 2018
    Inventors: Hetal Sarvaiya, Nathaniel J. Washburn, Enrique Arevalo, Carlos J. Bosques
  • Patent number: 9890410
    Abstract: The present invention provides methods of evaluating a glycoprotein preparation for the absence, presence or amount of an N-acetylhexosamine glycan, e.g., an N-acetylglucosamine glycan.
    Type: Grant
    Filed: September 9, 2015
    Date of Patent: February 13, 2018
    Assignee: MOMENTA PHARMACEUTICALS, INC.
    Inventors: Nathaniel Washburn, Enrique Arevalo, Kevin Millea, Carlos J. Bosques, Jay Duffner, Brian Edward Collins
  • Publication number: 20160060675
    Abstract: The present invention provides methods of evaluating a glycoprotein preparation for the absence, presence or amount of an N-acetylhexosamine glycan, e.g., an N-acetylglucosamine glycan.
    Type: Application
    Filed: September 9, 2015
    Publication date: March 3, 2016
    Inventors: Nathaniel Washburn, Enrique Arevalo, Kevin Millea, Carlos J. Bosques, Jay Duffner, Brian Edward Collins
  • Patent number: 9170249
    Abstract: The present invention provides methods of evaluating a glycoprotein preparation for the absence, presence or amount of an N-acetylhexosamine glycan, e.g., an N-acetylglucosamine glycan.
    Type: Grant
    Filed: March 12, 2012
    Date of Patent: October 27, 2015
    Assignee: MOMENTA PHARMACEUTICALS, INC.
    Inventors: Nathaniel J. Washburn, Enrique Arevalo, Kevin Millea, Carlos J. Bosques, Jay Duffner, Brian E. Collins
  • Publication number: 20150275266
    Abstract: The present disclosure relates to methods of evaluating, identifying, and/or producing (e.g., manufacturing) pharmaceutical products (e.g., protein therapeutics). In some instances, methods herein allow highly resolved evaluation of the disulfide bond profiles of protein therapeutics.
    Type: Application
    Filed: March 25, 2015
    Publication date: October 1, 2015
    Inventors: Brian COLLINS, John ROBBLEE, Nathaniel WASHBURN, Yan YIN, Enrique Arevalo
  • Publication number: 20150210753
    Abstract: Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.
    Type: Application
    Filed: July 25, 2013
    Publication date: July 30, 2015
    Applicant: Momenta Pharmaceuticals, Inc.
    Inventors: Hetal Sarvaiya, Nathaniel Washburn, Enrique Arevalo, Carlos J. Bosques
  • Publication number: 20120295273
    Abstract: The present invention provides methods of evaluating a glycoprotein preparation for the absence, presence or amount of an N-acetylhexosamine glycan, e.g., an N-acetylglucosamine glycan.
    Type: Application
    Filed: March 12, 2012
    Publication date: November 22, 2012
    Inventors: Nathaniel J. Washburn, Enrique Arevalo, Kevin Millea, Carlos J. Bosques, Jay Duffner, Brian E. Collins